BARD1 Life Sciences Health Care
Cancer Health Care Healthcare

$1.035 (0%)

High -	Low -	Trades -	Turnover $0	Volume 0
3 August 2026 at 10:26pm

Market Cap (9-Feb) $95,239,352 (971st)	Close (9-Dec) $1.04 0 (0%)	Volume (9-Dec) 0	Shortsold (3-Dec) 50,000 (0.05%) (513th)
52w High $0.000	52w Low $0.000	P/E -	EPS -0.144

Short Interest

ASIC data, 3 Dec 2021

% Shorted

0.05%

vs 0.05% prior report

Most Shorted Rank

513th

of 710 shorted ASX stocks

Peak Short

0.14%

Jul 2021

Days to Cover

0.4

at 50d avg vol

View full short position history →

	Subject
	BD1 BD1 Ann: BARD1 Files Two New Patents Protecting SubB2M & EXO-NET
	1 (current) 2 3
	BD1 BD1 Ann: BARD1 EXO-NET Exosome Data Presented at ISEV2021 Conference
	BD1 BD1 Ann: BARD1 Launches its RUO EXO-NET Product
	BD1 BD1 Ann: Appendix 4C and Quarterly Activities Report
	BD1 BD1 Ann: Positive Results from the BARD1 Autoantibody Assay
	BD1 BD1 Ann: Appendix 3G - Long Term Incentive Options Issued to CEO
	BD1 BD1 Ann: BARD1 Signs Option Agreement for Type 3C Diabetes Test
	BD1 BD1 Ann: Appendix 2A
	BD1 BD1 Ann: Positive Results Evaluation of EXO-NET in Pancreatic Cancer
	BD1 BD1 Ann: Appendix 2A
	BD1 BD1 Ann: Australian Patent Granted for hTERT
	BD1 BD1 Ann: BARD1 Achieves hTERT Registration and First Order in Korea
	BD1 BD1 Ann: Appendix 2A
	BD1 BD1 Ann: Change in substantial holding
	BD1 BD1 Ann: Ceasing to be a substantial holder
	BD1 BD1 Ann: Appendix 4D and Half-year financial report
	BD1 BD1 Ann: Commencement of Legal Proceedings Against BARD1
	BD1 BD1 Ann: Appendix 2A
	BD1 BD1 Ann: Ceasing to be a substantial holder
	BD1 BD1 Ann: Becoming a substantial holder
	BD1 BD1 Ann: Excellent SubB2M Breast Cancer Test Data
	BD1 BD1 Ann: Outstanding SubB2M Ovarian Cancer Test Data
	BD1 BD1 Ann: Change of Auditor
	BD1 BD1 Ann: Appendix 4C & Quarterly Activities Report
	BD1 BD1 Ann: U.S. Patent Granted for NET Technology for Exosome Capture
	BD1 BD1 Ann: Final Director's Interest Notice - Dr Irminger-Finger
	BD1 BD1 Ann: Dr Irminger steps down from Board, continues as Consultant
	BD1 BD1 Ann: Change of Director's Interest Notice - Cumming
	BD1 BD1 Ann: Change of Director's Interest Notice - Powell
	BD1 BD1 Ann: Change of Director's Interest Notice - Johnston
	BD1 BD1 Ann: Final Director's Interest Notice - Helen Fisher
	BD1 BD1 Ann: Patent Granted in China for hTERT
	BD1 BD1 Ann: Further Detail on BARD1's US Sales Strategy
	BD1 BD1 Ann: Trading Halt
	BD1 BD1 Ann: Pause in Trading
	BD1 BD1 Ann: Results of Meeting
	BD1 BD1 Ann: AGM & CEO Presentations and Chairman's Transcript
	BD1 BD1 Ann: Consolidation/Split - BD1
	BD1 BD1 Ann: Helen Fisher Steps Down from BARD1 Board
	BD1 BD1 Ann: BARD1 Gains New High-volume Customer for its hTERT Test
	BD1 BD1 Ann: Appendix 4C and Quarterly Activities Report
	BD1 BD1 Ann: Notice of Annual General Meeting/Proxy Form
	BD1 BD1 Ann: Notice of AGM ASX Listing Rule 3.13.1

Similar Companies

Apiam Animal Health

AHX

Capitol Health

CAJ

Healthia

HLA

Healius

HLS

Integral Diagnostics

IDX

Rhythm Biosciences

RHY

Sonic Healthcare

SHL

SILK Laser Australia Ltd

SLA

Total Brain

TTB

End of Day Prices

Date	Close	Volume	Change
09-Feb	$1.04	38,859	0.00 (0.00%)
08-Feb	$1.04	46,614	-0.01 (1.42%)
07-Feb	$1.06	72,356	+0.01 (1.44%)
03-Feb	$1.04	65,858	-0.04 (4.15%)
02-Feb	$1.09	58,392	+0.02 (2.36%)
01-Feb	$1.06	55,908	+0.06 (5.47%)
31-Jan	$1.01	67,379	-0.02 (1.95%)
27-Jan	$1.03	226,270	0.00 (0.00%)
25-Jan	$1.03	91,169	-0.03 (2.38%)
24-Jan	$1.05	246,594	-0.08 (7.08%)
21-Jan	$1.13	94,966	-0.06 (4.64%)
20-Jan	$1.19	90,105	0.00 (0.00%)
19-Jan	$1.19	157,018	-0.01 (0.84%)
18-Jan	$1.20	117,283	0.00 (0.00%)
17-Jan	$1.20	82,826	-0.01 (1.24%)
3 up, 8 down, and 4 flat days

BARD1 Life Sciences Health Care
Cancer Health Care Healthcare

Short Interest

Followers

Prices

Announcements

Similar Companies

End of Day Prices

BARD1 Life Sciences Health Care Cancer Health Care Healthcare

Short Interest

Followers

Prices

Announcements

Similar Companies

End of Day Prices

BARD1 Life Sciences Health Care
Cancer Health Care Healthcare